+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Disruptor Profile: Pear Therapeutics, Inc.

  • PDF Icon

    Company Profile

  • 11 Pages
  • June 2019
  • GlobalData
  • ID: 4791127
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Disruptor Profile: Pear Therapeutics, Inc.


The report provides information and insights into Pear Therapeutics, Inc.'s, including -
  • Overview of the company and its product offering

  • Detailed insight into its business model, company type and headquarter

  • Information on partnership and funding

  • Biography of top management.

  • Pear Therapeutics Inc. (Pear) is a pioneer in software-based prescription digital therapeutics (PDT) for the treatment of severe diseases and serious medical conditions.

Reasons to buy
  • Gain insights into Pears's business operations.

  • Gain insights into funding and partnerships

  • Gain understanding about its technology focus.

Table of Contents

Company Overview
Technology Focus
Product Overview
Partnerships & Funding
Key Employees

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Sandoz

  • Novartis

  • EDBI Pte Ltd

  • Blue Water Life Science Fund LP

  • Bridge Builders Collaborative

  • 5AM Venture Management LLC

  • Novartis AG

  • TrustBridge Partners

  • Arboretum Ventures LLC

  • Temasek Holdings (Private) Ltd

  • JAZZ Venture Partners L.P.